Anti-MDA5 antibody [EPR6743]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
5
(2 Reviews)
|
(10 Publications)
Knockout Tested Rabbit Recombinant Monoclonal MDA5 antibody. Suitable for WB and reacts with Human samples. Cited in 10 publications.
View Alternative Names
MDA5, RH116, IFIH1, Interferon-induced helicase C domain-containing protein 1, Clinically amyopathic dermatomyositis autoantigen 140 kDa, Helicase with 2 CARD domains, Interferon-induced with helicase C domain protein 1, Melanoma differentiation-associated protein 5, Murabutide down-regulated protein, RIG-I-like receptor 2, RNA helicase-DEAD box protein 116, CADM-140 autoantigen, Helicard, MDA-5, RLR-2
- WB
Unknown
Western blot - Anti-MDA5 antibody [EPR6743] (AB126630)
All lanes:
Western blot - Anti-MDA5 antibody [EPR6743] (ab126630) at 1/1000 dilution
All lanes:
THP1 treated with LPS cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated antibody at 1/2000 dilution
Predicted band size: 117 kDa
false
- WB
Lab
Western blot - Anti-MDA5 antibody [EPR6743] (AB126630)
All lanes:
Western blot - Anti-MDA5 antibody [EPR6743] (ab126630) at 1/1000 dilution
Lane 1:
Wild-type Jurkat, LPS (1 ug/mL, 24 h) cell lysate at 20 µg
Lane 2:
Wild-type Jurkat, vehicle control LPS (0 ug/mL, 24 h) cell lysate at 20 µg
Lanes 3 - 4:
Western blot - Human IFIH1 knockout Jurkat cell line (<a href='/en-us/products/cell-lines/human-ifih1-knockout-jurkat-cell-line-ab305280'>ab305280</a>)
Lane 3:
IFIH1 knockout Jurkat, LPS (1 ug/mL, 24 h) cell lysate at 20 µg
Lane 4:
IFIH1 knockout Jurkat, vehicle control LPS (0 ug/mL, 24 h) cell lysate at 20 µg
Predicted band size: 117 kDa,90 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-MDA5 antibody [EPR6743] (AB126630)
ab126630 was shown to react with IFIH1 in wild-type DMS 53 cells in Western blot with loss of signal observed in a IFIH1 siRNA knockdown cell line. Cell lysates from wild-type DMS 53 transfected with either scrambled siRNA or IFIH1 siRNA were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab126630 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-MDA5 antibody [EPR6743] (ab126630) at 1/1000 dilution
Lane 1:
Wild-type DMS 53 transfected with scrambled siRNA control lysate at 30 µg
Lane 2:
DMS 53 transfected with siRNA specifically targeting IFIH1 cell lysate at 30 µg
Observed band size: 116 kDa
false
Related conjugates and formulations (1)
-
Anti-MDA5 antibody [EPR6743] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
In cellular defense mechanisms MDA5 plays an important role in initiating antiviral responses. It operates as part of a signaling complex that includes MAVS (mitochondrial antiviral-signaling protein) leading to the production of type I interferons and pro-inflammatory cytokines. These responses promote an antiviral state in host cells aiding in the containment and clearance of viral infections. MDA5 antibodies can be useful tools for studying these immune processes.
Pathways
MDA5 interacts with antiviral signaling pathways such as the IFN signaling pathway and the RIG-I-like receptor signaling pathway. Upon recognizing viral RNA MDA-5 cooperates with proteins like RIG-I and MAVS to activate downstream signaling cascades that mediate immune responses. This collaboration enables efficient viral recognition and response limiting viral replication and spread.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Autophagy 20:2133-2145 PubMed38762760
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed38334619
2024
Applications
Unspecified application
Species
Unspecified reactive species
Genome research 31:1174-1186 PubMed34158368
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell systems 12:304-323.e13 PubMed33740397
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:453 PubMed32532953
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 20:116 PubMed32308561
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of infectious diseases 221:647-659 PubMed31562757
2019
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular and infection microbiology 8:251 PubMed30087859
2018
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 52:1623-1632 PubMed29512705
2018
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2014:697837 PubMed24701034
2014
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com